期刊文献+

蛭丹消脂汤治疗气滞血瘀、痰湿内阻型冠心病60例疗效观察

Efficacy Observation of Zhidan Xiaozhi Decoction in 60 Cases of Coronary Heart Disease of Qi and Blood Stagnation Pattern and Internal Retention of Phlegm Damp Pattern
下载PDF
导出
摘要 目的观察蛭丹消脂汤治疗冠心病(气滞血瘀、痰湿内阻型)的临床疗效及其对血浆超敏C反应蛋白(hsCRP)、内皮素(ET)、血脂等的影响。方法将120例患者随机分为对照组和治疗组两组,每组60例。对照组采用西医常规治疗;治疗组在对照组治疗基础上加服蛭丹消脂汤。两组疗程均为4周,分别测定两组治疗前后的hsCRP、ET、血脂,并观察临床症状改善情况。结果治疗组临床症状改善的显效率、总有效率分别为63.3%、93.10%,对照组分别为40.0%、63.33%,两组比较,差异有统计学意义(P<0.01)。治疗后治疗组hsCRP、ET均明显降低,与本组治疗前比较,差异有统计学意义(P<0.01);且治疗组hsCRP、血脂改善与对照组比较,差异有统计学意义(P<0.05)。结论蛭丹消脂汤治疗气滞血瘀、痰湿内阻型冠心病,不仅能改善其临床症状,并能显著降低hsCRP、ET,改善血脂的异常。 Objective To observe the clinical efficacy of zhidan xiaozhi decoction on coronary heart disease(qi and blood stagnation pattern and internal retention of phlegm damp pattern)as well as its impacts on high sensitivity C reactive protein(hsCRP),endothelin(ET),blood lipid,etc.Methods 120 cases were divided randomly into a treatment group and a control group,60 cases in each one.In control group,the conventional treatment with western medicine was applied.In treatment group,on the basis of the treatment as control group,zhidan xiaozhi decoction was supplemented.The cases in either group were treated for 4 weeks.Before and after treatment,the levels of hsCRP,ET and blood lipid were detected in two groups separately and the improvements in clinical symptoms were observed.Results In treatment group,the remarkably effective rate of the improvements in clinical symptoms were 63.3% and the total effective rate was 93.10%.In control group,they were 40.0% and 63.33% separately.The statistical significant differences presented in comparison of two groups(P<0.01).After treatment,the levels of hsCRP and ET reduced apparently in treatment group,which was statistically and significantly different as compared with those before treatment(P<0.01).Additionally,the improvements in hsCRP and blood lipid after treatment in treatment group were different significantly in statistics as compared with those in control group(P<0.05).Conclusion In treatment of coronary heart disease of qi and blood stagnation pattern and internal retention of phlegm damp pattern,zhidan xiaozhi decoction not only relieves clinical symptoms,but also significantly reduces the levels of hsCRP and ET and improves in the abnormality of blood lipid.
作者 马晓梅
出处 《世界中西医结合杂志》 2011年第7期590-592,597,共4页 World Journal of Integrated Traditional and Western Medicine
关键词 冠心病 气滞血瘀 痰湿内阻 蛭丹消脂汤 Coronary heart disease Qi and blood stagnation Internal retention of phlegm damp Zhidan xiaozhi decoction
  • 相关文献

参考文献8

  • 1国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(2):75-75.
  • 2方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 3中华人民共和圈卫生部.中药新药临床研究指导原则[M].1993;41-55.
  • 4Ridker PM. High - sensitivity C - reactive protein : potential adjunct for global risk assessment in the primary prevention of cardiovascular disease [ J ]. Circulation ,2001,103 ( 13 ) : 1813 - 1818.
  • 5Lekakis JP,Papamichael CM, Vemmos CN, et al. Peripheral vascular endothelial dysfunction in patients with angina pectoris and normal coronary arteriograms [J]. J Ara Coil Cardiol, 1998,31 ( 3 ) : 541 - 546.
  • 6Harrison DG. Endothelial dysfunction in atherosclerosis [ J ]. Basic Res Cardiol, 1994,89 ( suppl 1 ) : s87 - 102.
  • 7李雷,杨荣礼,项洁,李平静,汪敏,杨煜,徐通达.雷氏丹参片对急性冠脉综合征高敏C-反应蛋白、血管性血友病因子及纤维蛋白原的影响[J].中成药,2006,28(4):523-525. 被引量:3
  • 8刘运芳,赵玉霞,于会明,钟丽红,张运.脑心通胶囊对代谢综合征患者左心室肥厚的影响[J].中医杂志,2006,47(8):594-595. 被引量:5

二级参考文献10

  • 1ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segnent elevation myocardial infarction.A report of American college of cardiology/American heart association task force or practice guidelinees[J].J Am Coll Cordiol,2000,36:970-1062.
  • 2Ridker P M.High-sensitivity C-reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease[J].Circulation,2001,103:1813-1818.
  • 3Leakukis JP,Papamichael CM,Vemmos CN,et al.Peripheral vascular endothelial dysfunction in patients with pectoris and normal coronary arterograms[J].JAm Coll Cardiol,1998,31:541-546.
  • 4arrison DG.Endothelial dysfunction in atherosclerosis[J].Basic Res Cardiol,1994,89(Suppl 1):87-102.
  • 5Blann AD,Tabemer DA.A reliable marker of endothelial cell dysfunction Dose it exist?[J].Br J Haematol,1995,90(2):244-248.
  • 6Zama AG,Helft G.The role of plaque rupture and thrombosis in coronary disease[J].Atherosclerosis,2000,149(2):251.
  • 7Third Report of the National Cholesterol Education Program(NCEP)Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults(Adult Treatment PanelⅢ):final report.Circulation,2002,106(25):3143~3421.
  • 8Palmieri V,Bella JN,Arnett DK,et al.Effect of type 2 diabetes melli-tus on left ventricular geometry and systolic function in hypertensive subjects:Hypertension Genetic Epidemiology Network(HyperGEN)study.Circulation,2001,103(1):102~107.
  • 9方宏,冯义柏.血管内皮细胞损伤与常见心血管疾病[J].心血管病学进展,2001,22(1):34-36. 被引量:28
  • 10周芳明,祝之明,于军,赵志钢,王彦,谭建聪.2型糖尿病合并原发性高血压患者的动态血压及脉压和左心室结构功能的关系[J].中国循环杂志,2002,17(5):350-353. 被引量:10

共引文献4171

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部